Thursday, November 04, 2004

DEA stops/ fears/fail$ FAQ publishing for HCProfs

BCC distribution to Northern California Pain Initiative email group

For your information from the American Alliance of Cancer Pain Initiatives

(AACPI)

----- Forwarded by May Sung/CA/ACS/US on 11/03/2004 09:12 AM -----

MattBromleymd bromley@wisc.edu

To: AACPI_State_Contacts@yahoogroups.com

cc:

Subject: [AACPI_State_Contacts] Response to the DEA withdrawing FAQ 11/03/2004 07:34AM Please respond toAACPI_State_Contacts

TO: State Pain Initiatives

As many of you may know the DEA withdrew the Frequently Asked Questions on prescription pain medications document that was crafted with experts in the pain community and released in August. Members of the pain community who participated in the drafting of the document were surprised and disappointed by the DEA's action. Their letter to the DEA is available through the link below. We will keep you posted of any further developments.

Matt Bromley

Communications and Policy Director

AACPI



On October 6, the University of Wisconsin Pain & Policy Studies Group

(PPSG) announced a communication we received from the Drug

Enforcement Administration (DEA) in which we were informed by letter,

dated October 4, 2004, that the DEA had rescinded it’s endorsement of

the recently publicized document, Prescription Pain Medications:

Frequently Asked Questions and Answers for Health Care Professionals

and Law Enforcement Personnel (FAQ). The DEA notified us that they

had removed the FAQ from their website, citing that the document

contained misstatements, and asked the PPSG to do likewise. The PPSG,

along with several other organizations housing the FAQ, removed the

document from their websites.

In response to this issue, members of the principal working group

involved in the FAQ (Steven Passik, PhD; Russell Portenoy, MD; and

David Joranson, MSSW) have written a letter to the DEA Administrator

Karen Tandy. The letter asks that the DEA: (1) publicly reaffirm its

commitment to achieving balance, (2) explain the misstatements in the

FAQ so they can be addressed, (3) advise as to whether the agency

plans to revive and disseminate the FAQ or a similar educational

effort, and (4) tell how the agency proposes to restart a dialogue

with the clinical community that is dedicated to pain management.

A copy of both letters can be seen on the PPSG website at the

following URL: http://www.medsch.wisc.edu/painpolicy/DEA/index.htm

<><>~<><>~<><>~<><>~<><>~<><>~<><>~<><>~<><>~<><>

Ms. Jody P. Garthwaite

Policy Specialist & Communications Coordinator

Pain & Policy Studies Group

University of Wisconsin Comprehensive Cancer Center

World Health Organization Collaborating Center

406 Science Drive, Suite 202

Madison, WI 53711-1068

254">ABC News: Girl With Rare Disease Doesn't Know Pain

0 Comments:

Post a Comment

<< Home